Therapeutic Effects of Apremilast on Enthesitis and Dactylitis in Real Clinical Setting: An Italian Multicenter Study. Alberto Lo Gullo , Andrea Becciolini , Simone Parisi , Patrizia Del Medico , Antonella Farina , Elisa Visalli , Ylenia Dal Bosco , Aldo Biagio Molica Colella , Federica Lumetti , Rosalba Caccavale , Palma Scolieri , Romina Andracco , Francesco Girelli , Elena Bravi , Matteo Colina , Alessandro Volpe , Aurora Ianniello , Maria Chiara Ditto , Valeria Nucera , Veronica Franchina , Ilaria Platé , Eleonora Di Donato , Giorgio Amato , Carlo Salvarani , Simone Bernardi , Gianluca Lucchini , Francesco De Lucia , Francesco Molica Colella , Daniele Santilli , Natalia Mansueto , Giulio Ferrero , Antonio Marchetta , Eugenio Arrigoni , Rosario Foti , Gilda Sandri , Vincenzo Bruzzese , Marino Paroli , Enrico Fusaro , Alarico Ariani Journal of clinical medicine（2023）
摘要
Eph and Dph PsA patients treated with apremilast experienced a significant improvement in enthesitis and dactylitis activity. After 1 year, enthesitis and dactylitis remission was achieved in more than one-third of patients.
更多 查看译文
关键词
apremilast, dactylitis, enthesitis, therapeutic effects
AI 理解论文
溯源树
样例
